{"transactions":[{"id":1595401,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":93473,"kind":"person","name":"Rothbaum Wayne P.","position":1,"cik":"0001423102","reported_name":"Rothbaum Wayne P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Restricted Stock Unit","published_at":"2024-03-05T22:56:48.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred restricted stock unit (\"DRSU\") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant.  Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"50% of the RSUs will vest on the 6-month anniversary of the date of grant and the remaining RSUs will vest on the one-year anniversary of the date of grant.  Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date."}],"balance_after":100000,"derivative":{"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-24-031114","document":"tm248017-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465924031114/tm248017-10_4seq1.xml","form_type":"4"}},{"id":1633403,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":93473,"kind":"person","name":"Rothbaum Wayne P.","position":1,"cik":"0001423102","reported_name":"Rothbaum Wayne P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-20T21:11:20.000Z","date":"2024-02-20","kind":"purchase","planned":false,"acquired":true,"shares":5000000,"price":9.15,"value":45750000.0,"ownership":{"direct":false,"nature":"By Quogue Capital LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Such shares purchased pursuant to Issuer's underwritten offering, which priced on 02/20/2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The numbers reported in column 5 exclude 1,932,667 shares of common stock underlying 1,932,667 shares of Series B Preferred Stock of the Issuer beneficially owned by Quogue Capital LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Such shares may be held directly by Quogue Capital LLC or are held by one or more entities controlled by Quogue Capital LLC. The reporting person is the sole managing member of Quogue Capital LLC, and therefore, he is deemed to beneficially own such shares of common stock of the Issuer."}],"balance_after":28067333,"source":{"system":"sec-edgar","filing":"0001104659-24-025520","document":"tm246751-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465924025520/tm246751-3_4seq1.xml","form_type":"4"}},{"id":1780046,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":93473,"kind":"person","name":"Rothbaum Wayne P.","position":1,"cik":"0001423102","reported_name":"Rothbaum Wayne P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-15T22:12:55.000Z","date":"2023-09-15","kind":"purchase","planned":false,"acquired":true,"shares":5000000,"price":5.3,"value":26500000.0,"ownership":{"direct":false,"nature":"By Quogue Capital LLC"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The numbers reported in column 5 exclude 1,932,667 shares of common stock underlying 1,932,667 shares of Series B Preferred Stock of the Issuer beneficially owned by Quogue Capital LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Such shares may be held directly by Quogue Capital LLC or are held by one or more entities controlled by Quogue Capital LLC. The reporting person is the sole managing member of Quogue Capital LLC, and therefore, he is deemed to beneficially own such shares of common stock of the Issuer."}],"balance_after":23067333,"source":{"system":"sec-edgar","filing":"0001104659-23-101299","document":"tm2326274-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465923101299/tm2326274-1_4seq1.xml","form_type":"4"}},{"id":2098119,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":93473,"kind":"person","name":"Rothbaum Wayne P.","position":1,"cik":"0001423102","reported_name":"Rothbaum Wayne P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-02T22:29:18.000Z","date":"2022-12-02","kind":"purchase","acquired":true,"shares":10000000,"price":6.5,"value":65000000.0,"ownership":{"direct":false,"nature":"By Quogue Capital LLC"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The numbers reported in column 5 exclude 1,932,667 shares of common stock underlying 1,932,667 shares of Series B Preferred Stock of the Issuer beneficially owned by Quogue Capital LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Such shares may be held directly by Quogue Capital LLC or are held by one or more entities controlled by Quogue Capital LLC. The reporting person is the sole managing member of Quogue Capital LLC, and therefore, he is deemed to beneficially own such shares of common stock of the Issuer."}],"balance_after":18067333,"source":{"system":"sec-edgar","filing":"0001104659-22-124196","document":"tm2231927-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465922124196/tm2231927-1_4seq1.xml","form_type":"4"}},{"id":2247342,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":93473,"kind":"person","name":"Rothbaum Wayne P.","position":1,"cik":"0001423102","reported_name":"Rothbaum Wayne P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-02T23:59:13.000Z","date":"2022-06-01","kind":"purchase","acquired":true,"shares":500000,"price":6.431,"value":3215500.0,"ownership":{"direct":false,"nature":"By Quogue Capital LLC"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The numbers reported in column 5 exclude 1,932,667 shares of common stock underlying 1,932,667 shares of Series B Preferred Stock of the Issuer beneficially owned by Quogue Capital LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Such shares may be held directly by Quogue Capital LLC or are held by one or more entities controlled by Quogue Capital LLC.  The reporting person is the sole managing member of Quogue Capital LLC, and therefore, he is deemed to beneficially own such shares of common stock of the Issuer."}],"balance_after":8067333,"source":{"system":"sec-edgar","filing":"0001104659-22-067757","document":"tm2217576d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465922067757/tm2217576d1_4.xml","form_type":"4"}},{"id":2247341,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":93473,"kind":"person","name":"Rothbaum Wayne P.","position":1,"cik":"0001423102","reported_name":"Rothbaum Wayne P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-02T23:59:13.000Z","date":"2022-05-31","kind":"purchase","acquired":true,"shares":500000,"price":6.7691,"value":3384550.0,"ownership":{"direct":false,"nature":"By Quogue Capital LLC"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The numbers reported in column 5 exclude 1,932,667 shares of common stock underlying 1,932,667 shares of Series B Preferred Stock of the Issuer beneficially owned by Quogue Capital LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Such shares may be held directly by Quogue Capital LLC or are held by one or more entities controlled by Quogue Capital LLC.  The reporting person is the sole managing member of Quogue Capital LLC, and therefore, he is deemed to beneficially own such shares of common stock of the Issuer."}],"balance_after":7567333,"source":{"system":"sec-edgar","filing":"0001104659-22-067757","document":"tm2217576d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465922067757/tm2217576d1_4.xml","form_type":"4"}},{"id":3739347,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":93473,"kind":"person","name":"Rothbaum Wayne P.","position":1,"cik":"0001423102","reported_name":"Rothbaum Wayne P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-07T21:32:49.000Z","date":"2018-12-06","kind":"purchase","acquired":true,"shares":300000,"price":9.86,"value":2958000.0,"ownership":{"direct":false,"nature":"By Quogue Capital LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is an average price. These shares were purchased by Quogue Capital LLC in multiple transactions at prices ranging from $9.40 to $10.07, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person is the managing member of Quogue Capital LLC and so may be deemed to beneficially own such shares of common stock. The numbers reported in column 6 exclude 1,932,667 shares of common stock underlying 1,932,667 shares of Series B Preferred Stock held by Quogue Capital LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person is the managing member of Quogue Capital LLC and so may be deemed to beneficially own such shares of common stock. The numbers reported in column 6 exclude 1,932,667 shares of common stock underlying 1,932,667 shares of Series B Preferred Stock held by Quogue Capital LLC."}],"balance_after":7067333,"source":{"system":"sec-edgar","filing":"0001144204-18-063613","document":"tv508656_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000114420418063613/tv508656_4.xml","form_type":"4"}},{"id":3739346,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":93473,"kind":"person","name":"Rothbaum Wayne P.","position":1,"cik":"0001423102","reported_name":"Rothbaum Wayne P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-07T21:32:49.000Z","date":"2018-12-04","kind":"purchase","acquired":true,"shares":921053,"price":10.31,"value":9496056.43,"ownership":{"direct":false,"nature":"By Quogue Capital LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased by Quogue Capital LLC in multiple transactions at prices ranging from $9.88 to $10.51, inclusive. The reporting person undertakes to provide to Iovance Biotherapeutics, Inc., the staff of the Securities and Exchange Commission, and others pursuant to applicable securities laws, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (1) and (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person is the managing member of Quogue Capital LLC and so may be deemed to beneficially own such shares of common stock. The numbers reported in column 6 exclude 1,932,667 shares of common stock underlying 1,932,667 shares of Series B Preferred Stock held by Quogue Capital LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person is the managing member of Quogue Capital LLC and so may be deemed to beneficially own such shares of common stock. The numbers reported in column 6 exclude 1,932,667 shares of common stock underlying 1,932,667 shares of Series B Preferred Stock held by Quogue Capital LLC."}],"balance_after":6767333,"source":{"system":"sec-edgar","filing":"0001144204-18-063613","document":"tv508656_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000114420418063613/tv508656_4.xml","form_type":"4"}}]}